Norvēģija -
norvēģu -
Statens legemiddelverk
ketorolac trometamol s.a.l.f. 30 mg/ ml
s.a.l.f s.p.a. laboratorio farmacologico - ketorolaktrometamol - injeksjonsvæske, oppløsning - 30 mg/ ml
Eiropas Savienība -
norvēģu -
EMA (European Medicines Agency)
zolgensma
novartis europharm limited - onasemnogene abeparvovec - muskelatrofi, spinal - andre legemidler for forstyrrelser i muskel-skjelettsystemet - zolgensma er angitt for behandling av:pasienter med 5q spinal muskel atrofi (sma) med en bi-genetisk mutasjon i smn1 genet og en klinisk diagnose av sma type 1, orpatients med 5q sma med en bi-genetisk mutasjon i smn1 genet og opp til 3 smn2 kopier av genet.
Eiropas Savienība -
norvēģu -
EMA (European Medicines Agency)
adcetris
takeda pharma a/s - brentuximab vedotin - lymphoma, non-hodgkin; hodgkin disease - antineoplastiske midler - hodgkin lymphomaadcetris is indicated for adult patients with previously untreated cd30+ stage iv hodgkin lymphoma (hl) in combination with doxorubicin, vinblastine and dacarbazine (avd). adcetris is indicated for the treatment of adult patients with cd30+ hl at increased risk of relapse or progression following autologous stem cell transplant (asct). adcetris is indicated for the treatment of adult patients with relapsed or refractory cd30+ hodgkin lymphoma (hl):following asct, orfollowing at least two prior therapies when asct or multi-agent chemotherapy is not a treatment option. systemic anaplastic large cell lymphomaadcetris in combination with cyclophosphamide, doxorubicin and prednisone (chp) is indicated for adult patients with previously untreated systemic anaplastic large cell lymphoma (salcl). adcetris is indicated for the treatment of adult patients with relapsed or refractory salcl. cutaneous t cell lymphomaadcetris is indicated for the treatment of adult patients with cd30+ cutaneous t cell lymphoma (ctcl) after at least 1 prior systemic therapy.
Eiropas Savienība -
norvēģu -
EMA (European Medicines Agency)
iblias
bayer ag - octocog alfa - hemofili a - antihemoragika - behandling og profylakse av blødning hos pasienter med hemofili a (medfødt faktor viii-mangel). iblias kan brukes for alle aldersgrupper.
Eiropas Savienība -
norvēģu -
EMA (European Medicines Agency)
kovaltry
bayer ag - octocog alfa - hemofili a - antihemoragika - behandling og profylakse av blødning hos pasienter med hemofili a (medfødt faktor viii-mangel). kovaltry kan brukes til alle aldersgrupper.
Norvēģija -
norvēģu -
Statens legemiddelverk
malarone 250 mg / 100 mg
glaxosmithkline as - atovakvon / proguanilhydroklorid - tablett, filmdrasjert - 250 mg / 100 mg
Eiropas Savienība -
norvēģu -
EMA (European Medicines Agency)
byfavo
paion deutschland gmbh - remimazolam besilate - bevisst sedasjon - psykoleptiske - remimazolam is indicated in adults for procedural sedation. remimazolam 50 mg is indicated in adults for intravenous induction and maintenance of general anaesthesia.
Norvēģija -
norvēģu -
Statens legemiddelverk
apocillin 330 mg
actavis group ptc ehf (1) - fenoksymetylpenicillinkalium - tablett, filmdrasjert - 330 mg
Norvēģija -
norvēģu -
Statens legemiddelverk
apocillin 250 mg/ ml
actavis group ptc ehf (1) - fenoksymetylpenicillinkalium - granulat til dråper, oppløsning - 250 mg/ ml
Norvēģija -
norvēģu -
Statens legemiddelverk
apocillin 50 mg/ ml
actavis group ptc ehf (1) - fenoksymetylpenicillinkalium - granulat til mikstur, oppløsning - 50 mg/ ml